Aspira Pathlab & Diagnostics (BOM:540788) Net Margin % : -13.19% (As of Mar. 2024)

Aspira Pathlab & Diagnostics Net Margin % Chart

Aspira Pathlab & Diagnostics Annual Data
	Trend	Mar15	Mar16	Mar17	Mar18	Mar19	Mar20	Mar21	Mar22	Mar23	Mar24
Net Margin %		Get a 7-Day Free Trial					-50.38	9.08	22.82	-0.61	-20.24

Aspira Pathlab & Diagnostics Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Net Margin %	Get a 7-Day Free Trial															-7.61	-27.50	-21.40	-21.43	-13.19

Competitive Comparison of Aspira Pathlab & Diagnostics's Net Margin %

For the Diagnostics & Research subindustry, Aspira Pathlab & Diagnostics's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Aspira Pathlab & Diagnostics's Net Margin % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Aspira Pathlab & Diagnostics's Net Margin % distribution charts can be found below:

* The bar in red indicates where Aspira Pathlab & Diagnostics's Net Margin % falls into.

Aspira Pathlab & Diagnostics Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Aspira Pathlab & Diagnostics's Net Margin for the fiscal year that ended in Mar. 2024 is calculated as

Aspira Pathlab & Diagnostics's Net Margin for the quarter that ended in Mar. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aspira Pathlab & Diagnostics  (BOM:540788) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Aspira Pathlab & Diagnostics Net Margin % Related Terms

Thank you for viewing the detailed overview of Aspira Pathlab & Diagnostics's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Aspira Pathlab & Diagnostics (BOM:540788) Business Description